 
            
        Leaders
The focus of our research is on tumor microenvironment (TME). Our overall goal is to elucidate how stromal cells, like fibroblasts and immune cells, and extracellular matrix molecules like hyaluronan affect melanoma progression and ICI-therapy (immune check point inhibitor) response. We are interested in tumor immunology, the role of macrophages and FoxP3+ regulatory T-cells in the formation of immunosuppressive TME in melanoma. The role of immune cells in tumor dissemination is well established yet the mechanisms that recruit the immune cells and regulate their function in the TME are poorly understood at the moment and are the targets of our research. In addition, we are seeking for new prognostic and predictive ICI-therapy response biomarkers in melanoma.
News
- 
					 Inflammatory cells in tumour microenvironment promote the transformation of prostate cancer cells into treatment-resistant cells Inflammatory cells in tumour microenvironment promote the transformation of prostate cancer cells into treatment-resistant cellsInflammatory cells in tumour microenvironment promote the transformation of prostate cancer cells into treatment-resistant cells
- 
					 The 16th FCI Symposium 26.-27.9.2024 - Future of Clinical Decision Making The 16th FCI Symposium 26.-27.9.2024 - Future of Clinical Decision MakingThe 16th FCI Symposium 26.-27.9.2024 - Future of Clinical Decision Making
- 
					 Cancer and Extracellular vesicles summer school 1.-2.6.2022 Cancer and Extracellular vesicles summer school 1.-2.6.2022Cancer and Extracellular vesicles summer school 1.-2.6.2022
Cooperation
- 
                                    
                                        UEF 
- 
                                    
                                        Lerner Research Institute, Cleveland Clinic, Cleveland, USA 
- 
                                    
                                        UEF 
- 
                                    
                                        UEF, Faculty of Health Sciences 
- 
                                    
                                        Kuopio University Hospital 
- 
                                    
                                        UEF 
- 
                                    
                                        University of Helsinki 
- 
                                    
                                        University of Manchester 
Keywords
Leaders
Senior Researchers
Doctoral Researchers
- 
        
                              Kirsi KainulainenVisiting ResearcherInstitute of Biomedicine, School of Medicine, Faculty of Health Sciences
- 
        
                              Kaisa Mäki-MantilaDoctoral ResearcherInstitute of Biomedicine, School of Medicine, Faculty of Health Sciences
Technicians
Other group members
Publications
40 items- 
                                            
                                                Hyaluronan accumulation is associated with reduced hyaluronidase expression in renal cell carcinoma, with CD44, HAS1, and HYAL2 emerging as prognostic markersJokelainen, Otto; Rintala, Teemu; Remes, Satu; Pasonen-Seppänen, Sanna; Nykopp, Timo K.; Sironen, Reijo, 2025, The journal of pathology : Clinical research, 11, 4, e70035. A1 Journal article (refereed), original research
- 
                                            
                                                Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse eventsNurmela, Veera; Juntunen, Anni; Selander, Tuomas; Pasonen-Seppänen, Sanna; Kuittinen, Outi; Tiainen, Satu; Rönkä, Aino, 2025, Immunotherapy, 17, 5, 339-346. A1 Journal article (refereed), original research
- 
                                            
                                                Differential expression analysis identifies a prognostically significant extracellular matrix–enriched gene signature in hyaluronan-positive clear cell renal cell carcinomaJokelainen, Otto; Rintala, Teemu J; Fortino, Vittorio; Pasonen-Seppänen, Sanna; Sironen, Reijo; Nykopp, Timo K, 2024, Scientific reports, 14, 1, 10626. A1 Journal article (refereed), original research
- 
                                            
                                                Expression of Programmed Death Ligand 1 and Indoleamine 2,3‐Dioxygenase in Oral Lichen Planus and Oral Lichenoid LesionsKemppainen, Olli; Mathlin, Andreas; Pasonen‐Seppänen, Sanna; Siponen, Maria, 2024, Journal of oral pathology and medicine, 53, 10, 613-621. A1 Journal article (refereed), original research
- 
                                            
                                                Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cellsDeen, Ashik Jawahar; Adinolfi, Simone; Härkönen, Jouni; Patinen, Tommi; Liu, Xiaonan; Laitinen, Tuomo; Takabe, Piia; Kainulainen, Kirsi; Pasonen-Seppänen, Sanna; Gawriyski, Lisa M; Arasu, Uma Thanigai; Selvarajan, Ilakya; Mäkinen, Petri; Laitinen, Hanna; Kansanen, Emilia; Kaikkonen, Minna U; Poso, Antti; Varjosalo, Markku; Levonen, Anna-Liisa, 2024, Redox biology, 69, 103031. A1 Journal article (refereed), original research
- 
                                            
                                                Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NFκB-signalingKainulainen, Kirsi; Niskanen, Einari A; Kinnunen, Johanna; Mäki-Mantila, Kaisa; Hartikainen, Kiia; Paakinaho, Ville; Malinen, Marjo; Ketola, Kirsi; Pasonen-Seppänen, Sanna, 2024, Oncoimmunology, 13, 1, 2393442. A1 Journal article (refereed), original research
- 
                                            
                                                A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitorsTiainen, Satu; Nurmela, Veera; Selander, Tuomas; Turunen, Patrik; Pasonen-Seppänen, Sanna; Kettunen, Tiia; Kuittinen, Outi; Auvinen, Päivi; Rönkä, Aino, 2023, Bmc cancer, 23, 1, 1186. A1 Journal article (refereed), original research
- 
                                            
                                                Irradiation Alters the Expression of MUC1, CD44 and Hyaluronan in Oral Mucosal EpitheliumKashyap, Bina; Naumanen, Konsta; Mikkonen, Jopi; Dekker, Hannah; Schulten, Engelbert; Bloemena, Elisabeth; Pasonen-Seppänen, Sanna; Kullaa, Arja, 2022, Biomedicines, 10, 11, 2816. A1 Journal article (refereed), original research
- 
                                            
                                                M1 Macrophages Induce Protumor Inflammation in Melanoma Cells through TNFR–NF-κB SignalingKainulainen, Kirsi; Takabe, Piia; Heikkinen, Sami; Aaltonen, Niina; de la Motte, Carol; Rauhala, Leena; Durst, Franziska C; Oikari, Sanna; Hukkanen, Taija; Rahunen, Eija; Ikonen, Ella; Hartikainen, Jaana M; Ketola, Kirsi; Pasonen-Seppänen, Sanna, 2022, Journal of investigative dermatology, 1412, 11, 3041-3051.e10. A1 Journal article (refereed), original research
- 
                                            
                                                The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous MelanomaSalmi, Satu; Hälinen, Kaisla; Lin, Anton; Suikkanen, Sanna; Jokelainen, Otto; Rahunen, Eija; Siiskonen, Hanna; Pasonen-Seppänen, Sanna, 2022, Biomedicines, 10, 12, 3209. A1 Journal article (refereed), original research
 
                        